Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ondřej Rohleder"'
Autor:
Peter Múdry, Michal Kýr, Ondřej Rohleder, Michal Mahdal, Iva Staniczková Zambo, Marta Ježová, Tomáš Tomáš, Jaroslav Štěrba
Publikováno v:
Journal of Bone Oncology, Vol 28, Iss , Pp 100362- (2021)
Purpose: Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free survival (EFS) in localized disease is roughly 65 and 60%, respective
Externí odkaz:
https://doaj.org/article/d2c6f7ddce29434c93d6a72a9563cdf9
Autor:
Iva Staniczková Zambo, Michal Mahdal, Jaroslav Štěrba, Michal Kýr, Peter Múdry, Tomáš Tomáš, Ondřej Rohleder, Marta Ježová
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, Vol 28, Iss, Pp 100362-(2021)
Journal of Bone Oncology, Vol 28, Iss, Pp 100362-(2021)
Highlights • A report on the best treatment results on an osteosarcoma cohort. • There has been a lack of improvement in osteosarcoma treatment for the last four decades. • Mifamurtide is the only new drug against osteosarcoma licensed by the E
Background Conventional osteosarcoma is rare disease. Current treatment approaches have been set decades ago and include combination of three drug chemotherapy schedule and surgery. Three and five years event free survival in localized disease is rou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfc3192ef5afc741fb66364ab78b1e97
https://doi.org/10.21203/rs.2.14968/v1
https://doi.org/10.21203/rs.2.14968/v1
Publikováno v:
Onkologie. 10:224-227
Rabdomyosarkom je nejcastějsi sarkom měkkých tkani u děti. Soucasne standardy lecby prvni linie jsou definovany protokoly severoamericke COG a evropske kooperativni skupiny EpSSG. Stratifikacni kriteria poměrně spolehlivě predikuji přežiti p